Nuwellis, Inc.
NUWE$4.33
+$2.44 (129.34%)
OpenNasdaq non-compliance letter for minimum bid price triggers NUWE 28.5% premarket plunge
Loading chart...
IndexN/A
Market Cap0.00B
Enterprise Value0.01B
Income$-0.00B
Sales$0.00B
EmployeesN/A
P/E-1.90
P/S1.45
P/B4.58
P/C-1.10
EV/EBITDA-1.72
EV/SalesN/A
EPS (ttm)-2.28
EarningsN/A
Gross Margin61.96%
Oper. Margin-134.29%
Profit Margin-211.86%
Volume107.64M
Shs Outstand0.00B
Change129.34%
Dividend Est.N/A
Dividend Ex-DateN/A
Perf YTDN/A
Perf YearN/A
Perf 3YN/A
Perf 5YN/A
Perf 10YN/A
IPON/A
Jun 809:46PMNuwellis Announces Closing of $6.0 Million Registered Public Offering(globenewswire.com)
May 1210:40AMNuwellis, Inc. (NUWE) Q1 2026 Earnings Call Transcript(seekingalpha.com)08:00AMNuwellis, Inc. Announces First Quarter 2026 Financial Results(globenewswire.com)
Apr 2908:30AMNuwellis Highlights Case Study Featuring Precision Ultrafiltration Therapy in Pediatric Cardiorenal Care at ISHLT 2026 Annual Meeting(globenewswire.com)08:30AMNuwellis Highlights Case Study Featuring Precision Ultrafiltration Therapy in Pediatric Cardiorenal Care at ISHLT 2026 Annual Meeting(globenewswire.com)
Insider Trading
No insider trades found for NUWE.
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.74M | $8.86M | $8.54M | $7.92M | $7.44M | $5.51M | $5.00M | $3.55M |
| Cost of Revenue | $2.91M | $3.88M | $3.79M | $3.43M | $3.38M | $2.66M | $3.67M | $2.76M |
| Gross Profit | $5.83M | $4.98M | $4.75M | $4.49M | $4.06M | $2.85M | $1.33M | $790.00K |
| Gross Margin | 66.66% | 56.22% | 55.66% | 56.70% | 54.52% | 51.73% | 26.57% | 22.23% |
| Operating Expenses | $16.81M | $22.61M | $21.93M | $24.02M | $21.09M | $20.96M | $18.36M | $15.60M |
| Operating Income | $-10.99M | $-17.63M | $-17.17M | $-19.53M | $-17.03M | $-18.11M | $-17.04M | $-14.81M |
| Operating Margin | -125.72% | -198.89% | -200.99% | -246.51% | -228.84% | -328.54% | -340.86% | -416.89% |
| Net Income | $-11.16M | $-20.21M | $-14.53M | $-19.55M | $-15.84M | $-18.11M | $-17.03M | $-13.38M |
| Net Margin | -127.75% | -227.99% | -170.02% | -246.86% | -212.82% | -328.69% | -340.78% | -376.64% |
| EPS (Basic) | $-8.00 | $-360.07 | $-2921.95 | $-10004.09 | $-20276.57 | $-411681.82 | $-4258000.00 | $-4460666.67 |
| EBITDA | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Stock Option Compensation Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price To Earnings Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price To Sales Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Capitalization | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Discover more
You may be interested in